Calls Purchased on Exact Sciences Corporation

Shares of Exact Sciences Corporation EXAS are higher on the session by 2.77%, currently trading at $7.24. The stock has been moving largely higher over the past three months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A short while ago the July 2011 $6.00 call was purchased 1,000 times, on the offer, on open interest of 1,719 contracts. Overall call volume is now running at 4.84x the daily average with 91% of all calls traded being purchases on the offer. Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. It has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer.